
uMed’s AccessPD Interactive Parkinson’s Registry Surpasses 1000 Participants
uMed has announced that its pioneering AccessPD Parkinson’s Disease Interactive registry has surpassed 1,000 participants. This milestone marks a significant…
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
uMed has announced that its pioneering AccessPD Parkinson’s Disease Interactive registry has surpassed 1,000 participants. This milestone marks a significant…
New collaboration launches at ISPOR 2024, offering pharmaceutical and biotech companies rapid access to unique, customisable data and expert guidance…
In this article with Pharmaceutical Executive, uMed CEO & Founder, Dr Matt Wilson, discusses the need for robust evidence that…
View the poster here. ILD is a group of rare, heterogeneous conditions causing lung fibrosis and inflammation. Different trajectories across…
Launched in September 2022, AccessPD aims to address the challenges of PD research by leveraging electronic health records and electronic…
A Novel Approach to Patient Recruitment and Data Collection The burden of cardiometabolic diseases (CMD) such as diabetes, heart disease,…